GLO1 and diabetic kidney disease: Finally, the upregulation of GLO1 and aldose reductase were protective against diabetic nephropathy alterations in diabetic patients [173] suggesting that boosting this system could be a possible therapeutic approach to delay the development of age-related diseases.